Physician Group M&A Valuation Report - All

Comparable Transactions / Precedent Deals


Excel spreadsheet with Scope Research's physician group M&A valuation data and benchmarking tools. Transactions segmented by type, which includes multi-specialty, anesthesia, dermatology, cardiology, radiology, ER/ED, urgent care, and pathology, among others. The transactions mostly consist of large, multi-location groups.


  • 175 transactions with revenue or EBITDA multiples (since 2010)
  • 110 of these deals have reported EBITDA Multiples
  • Median multiple of 1.6x revenue and 10.6x EBITDA
  • Last updated 6/24/2022


Each transaction includes price to revenue and/or EBITDA multiples. We provide the names of the parties, transaction date, ownership percentage acquired, deal price (stated on a total enterprise value basis), time period of the financial information relied upon, revenue and/or EBITDA, and a description of our source documents and key details related to the financial information presented. 


Visit for more information about our firm, process, and healthcare M&A data. Questions? Reach out to for more information.

All transactions included in the Scope Research healthcare M&A databases are meticulously researched and sourced from public documentation. Our internal records include an audit trail of links to our sources, which include:


  • Fairness opinions
  • SEC filings
  • Press releases
  • Bond market research
  • Medicare cost reports
  • CON filings (FOIA)
  • Form 990s
  • Public audits
  • AG reports
  • Insurance department filings

Physician Groups